SCHEMBL24011109

SCHEMBL24011109

Cc1ccccc1C(=O)NCCCCCNC(=O)NCc1ccc(Cl)cc1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 4/20 0.57
▸ SMN1; SMN2 Q16637 2/20 0.57
▸ MEN1 O00255 2/20 0.54
▸ KMT2A Q03164 2/20 0.54
▸ MAPK1 P28482 1/20 0.52
▸ SLC6A5 Q9Y345 1/20 0.48
▸ HDAC3 O15379 1/20 0.48
▸ LMNA P02545 2/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ MAPT P10636 1/20 0.48
▸ P2RX7 Q99572 1/20 0.47
▸ NPC1 O15118 2/20 0.47
▸ RAB9A P51151 2/20 0.47
▸ HTT P42858 2/20 0.47
▸ GAA P10253 1/20 0.47
▸ ATM Q13315 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ ALOX15 P16050 1/20 0.47
▸ EPHX2 P34913 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30634157 1.00 HPGD (0.57) HPGDSMN1; SMN2MEN1KMT2AMAPK1
SCHEMBL26784046 0.89 HPGD (0.59) HPGDSMN1; SMN2MEN1KMT2AMAPK1
SCHEMBL24011672 0.85 ALDH1A1 (0.55) HPGDSMN1; SMN2MEN1KMT2ASLC6A5
SCHEMBL9492896 0.81 HPGD (0.77) HPGDSMN1; SMN2MEN1KMT2AMAPK1
SCHEMBL26633783 0.80 MEN1 (0.69) SMN1; SMN2MEN1KMT2AHDAC3LMNA
SCHEMBL24011667 0.79 ALDH1A1 (0.55) HPGDMEN1KMT2AHDAC3ALDH1A1
SCHEMBL24011673 0.79 CA1 (0.53) MEN1KMT2AHDAC3ALDH1A1MAPT
SCHEMBL30634129 0.79 CA1 (0.53) MEN1KMT2AHDAC3ALDH1A1MAPT
SCHEMBL19153537 0.79 SMN1; SMN2 (0.65) HPGDSMN1; SMN2MEN1KMT2ASLC6A5
SCHEMBL24011473 0.79 EPHX1 (0.62) HPGDSMN1; SMN2MEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
CN-115843295-A NAMPT modulators 赛特凯恩蒂克公司 2023-03-24 — — CN disclosed
WO-2021226276-A2 NAMPT MODULATORS CYTOKINETICS, INC. (US) 2021-11-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348369-A1 NAMPT MODULATORS NAMPT, NNT, NAPRT HPGD 283/4885SMN1; SMN2 610/4885MEN1 110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback